Matches in Wikidata for { <http://www.wikidata.org/entity/Q91570597> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q91570597 description "artículu científicu espublizáu en marzu de 2019" @default.
- Q91570597 description "scientific article published on 29 March 2019" @default.
- Q91570597 description "wetenschappelijk artikel" @default.
- Q91570597 description "наукова стаття, опублікована 29 березня 2019" @default.
- Q91570597 name "Body weight and eGFR during dulaglutide treatment in type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7)" @default.
- Q91570597 name "Body weight and eGFR during dulaglutide treatment in type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7)" @default.
- Q91570597 type Item @default.
- Q91570597 label "Body weight and eGFR during dulaglutide treatment in type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7)" @default.
- Q91570597 label "Body weight and eGFR during dulaglutide treatment in type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7)" @default.
- Q91570597 prefLabel "Body weight and eGFR during dulaglutide treatment in type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7)" @default.
- Q91570597 prefLabel "Body weight and eGFR during dulaglutide treatment in type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7)" @default.
- Q91570597 P1433 Q91570597-A277865C-E4CD-4C4F-B552-1F7244507089 @default.
- Q91570597 P1476 Q91570597-E28DA75D-2649-40DB-A59E-46634A4787C7 @default.
- Q91570597 P2093 Q91570597-0E7F184B-A6CA-4158-858D-6FAAA2A7AAC3 @default.
- Q91570597 P2093 Q91570597-2D2CBD9E-A53A-4710-898E-2543C6335F92 @default.
- Q91570597 P2093 Q91570597-39CEF920-A484-4844-BA66-9B55F8C749F7 @default.
- Q91570597 P2093 Q91570597-7518A567-17E6-410B-87A1-43B0E0F80D08 @default.
- Q91570597 P2093 Q91570597-898CDBE1-75B6-4FC2-9117-D5E4303FCDE7 @default.
- Q91570597 P304 Q91570597-DD980A60-04F9-45CB-B73A-134D5B9C5F2F @default.
- Q91570597 P31 Q91570597-83F9A60C-5443-46B0-A20D-A83F1CB5D7E7 @default.
- Q91570597 P356 Q91570597-593C5B8D-8998-479D-85B7-7B3C835C9EE0 @default.
- Q91570597 P433 Q91570597-59044C5A-09EA-4A11-8AC8-51FF1EE78958 @default.
- Q91570597 P478 Q91570597-28882B6C-214D-483D-8968-A62725F3A7C4 @default.
- Q91570597 P50 Q91570597-3CB24BDB-0772-4837-8023-CE511E807FE6 @default.
- Q91570597 P577 Q91570597-D34D5DE0-087F-4635-AF6A-87EFA95E1B36 @default.
- Q91570597 P698 Q91570597-A51276B2-5ED5-4902-A159-4E29A2CB740D @default.
- Q91570597 P921 Q91570597-1A6F1ABF-1FD2-4BE0-9FDF-C49DBB4503F0 @default.
- Q91570597 P921 Q91570597-7A431277-A591-4913-8299-619F31451F4D @default.
- Q91570597 P356 DOM.13668 @default.
- Q91570597 P698 30762290 @default.
- Q91570597 P1433 Q5270109 @default.
- Q91570597 P1476 "Body weight and eGFR during dulaglutide treatment in type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7)" @default.
- Q91570597 P2093 "Alan G Zimmermann" @default.
- Q91570597 P2093 "Brad Woodward" @default.
- Q91570597 P2093 "Brian Rayner" @default.
- Q91570597 P2093 "Katherine R Tuttle" @default.
- Q91570597 P2093 "Mark C Lakshmanan" @default.
- Q91570597 P304 "1493-1497" @default.
- Q91570597 P31 Q13442814 @default.
- Q91570597 P356 "10.1111/DOM.13668" @default.
- Q91570597 P433 "6" @default.
- Q91570597 P478 "21" @default.
- Q91570597 P50 Q91570592 @default.
- Q91570597 P577 "2019-03-29T00:00:00Z" @default.
- Q91570597 P698 "30762290" @default.
- Q91570597 P921 Q3025883 @default.
- Q91570597 P921 Q736715 @default.